Safyral and other popular birth control drugs containing the hormone drospirenone have been linked to blood clots, cardiac arrest, gallbladder disease and even death. Between 2004 and 2008, over 50 deaths have been attributed to drospirenone-containing medications around the country. Women taking Safyral are urged to consult a healthcare professional about the risks of birth control side effects.
Safyral Blood Clot Lawsuit Update 4/13/12: Pharmaceutical giant Bayer will pay at least $110 million to settle approximately 500 lawsuits over claims that its controversial line of Yasmin birth control products cause blood clots. Officials of Germany’s largest drugmaker reportedly agreed to pay an average of about $220,000 a case to resolve the complaints, people familiar with the agreements said.
Safyral Blood Clot Update 4/10/12: Birth control products containing the synthetic hormone drospirenone have been linked to an increased risk for blood clots, according to a warning issued today by the U.S. Food & Drug Administration (FDA). In response to these findings, the FDA has required that all drospirenone-containing contraceptives carry warnings which state that several studies have found as much as a three-fold increased risk of blood clots associated with drospirenone when compared to levonorgestrel, a different hormone found in many older forms of birth control.
Safyral Blood Clot Update 12/9/11: An independent advisory panel to the FDA has recommended that all birth control products containing the hormone drospirenone should have their labels updated to include warnings about blood clots. The panel’s recommendation was based on new data suggesting that the popular contraceptives may put women at a higher risk for dangerous blood clots than older forms of birth control.
Free Safyral Lawsuit Evaluation: If you or a loved one suffered a blood clot after taking Safyral, you should contact our law firm immediately. You may be entitled to compensation by filing a suit against the manufacturer and our lawyers can help.
Safyral (drospirenone/ethinyl estradiol/levomefolate calcium) is an oral contraceptive that has been approved by the U.S. Food & Drug Administration (FDA) to prevent pregnancy and provide folate supplementation. Manufactured and marketed by Bayer HealthCare Pharmaceuticals, Inc., Safyral prevents pregnancy by:
- stopping ovulation (the maturation and release of eggs from the ovaries).
- altering the cervical mucus, which makes it more difficult for sperm to enter the uterus.
- changing the lining of the uterus (the endometrium), making it less receptive to an embryo.
Safyral is fundamentally different from many other forms of birth control in that it contains drospirenone, a chemical that works against testosterone and other male hormones. Unfortunately, drospirenone can cause problems because it may increase the level of potassium in your blood, which can be a problem for some women. In fact, drospirenone has recently been linked to an increased risk of blood clots and other serious side effects in certain users.
Side Effects of Safyral
The drospirenone in Safyral has been known to lead to serious health problems including (but not limited to):
- Blood Clots
- Deep Vein Thrombosis (DVT)
- Venous Thromboembolism (VTE)
- Pulmonary Embolism (PE)
- Cerebrovascular Accidents (CVA)
- Heart Attack
- Myocardial Infarction
- Gallbladder Disease / Injury (cholecystitis)
- Gallbladder Removal (cholecystectomy)
On May 31, 2011, the FDA issued a press release warning about the increased risk of blood clots in birth control pills containing drospirenone. The warning was prompted by two recent studies that came to the attention of the administration evaluating the risk of venous thromboembolism (VTE) in women who use drospirenone-containing medications. The studies focused on whether there is a higher risk of blood clots in women taking contraceptives with drospirenone versus women taking birth control pills with levonorgestrel, a hormone found in many older, so-called ‘second generation’ birth control products. The collective results found a significantly greater risk of VTE associated with birth control pills that contain drospirenone:
“This risk is reported to be up to 2 to 3 times greater than the risk of VTE associated with using levonorgestrel-containing pills. Other studies have not reported an increase in risk. The FDA is currently evaluating the conflicting results from these studies and will look at all currently available information to fully assess the risks and benefits of drospirenone-containing birth control pills.”
If you are taking Safyral
Do not take Safyral if you are pregnant or planning to become pregnant. If you have recently given birth, wait until you stop breast feeding before taking Safyral. Additionally, avoid taking Safyral if you have any of the following conditions:
- a heart valve disorder, blood-clotting disorder, uncontrolled high blood pressure, coronary heart disease, or severe migraine headaches;
- a history of heart attack, stroke, or blood clot (especially in your leg, lung, or eye);
- problems with your eyes, kidneys, or circulation caused by diabetes;
- kidney disease or adrenal gland disorder;
- liver disease or liver cancer;
- unusual vaginal bleeding;
- any type of breast, uterine, or hormone-dependent cancer;
- a history of jaundice caused by pregnancy; or
- if you are 35 or older and you smoke.
Do I Have a Safyral Lawsuit?
The Product Liability & Defective Drug Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Safyral lawsuits. We are handling individual litigation nationwide and currently accepting new blood clot cases in all 50 states.
Free Confidential Case Evaluation: Again, if you developed a blood clot after using Safyral, you should contact our law firm immediately. You may be entitled to compensation by filing a lawsuit and our lawyers can help.